| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,950 |
1,481 |
$82K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
668 |
548 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
505 |
442 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
798 |
445 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
938 |
714 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
157 |
127 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
21 |
14 |
$750.25 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
54 |
48 |
$685.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
14 |
$491.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
196 |
149 |
$126.92 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
385 |
301 |
$91.46 |